European Movers: Close Brothers (CBG LN) +19.8%, Antofagasta (ANTO LN) +15.0%, Evotec (EVT GY) +6.2%, Bayer (BAYN GY) +4.1%, Reckitt Benckiser (RKT LN) +4.0%, Danone (BN FP) +1.2%, Shell (SHEL LN) -9.0%

Bayer (BAYN GY) - Executive says no change to 2026 guidance due to US pharmaceutical tariffs announced last week. (Newswires)

Close Brothers (CBG LN) - Update following FCA's latest consumer redress scheme. The estimated cost of the scheme as published is c. GBP 320mln. This would reduce the group's CET 1 capital ratio by c.25 basis points to 14.0%, on a pro forma basis as at 31 January 2026. This remains comfortably ahead of the group's medium-term target of 12-13%. (Close Brothers) 

Danone (BN FP) - Co. is reportedly working with Centerview bank over a potential takeover of Reckitt Benckiser's (RKT LN) Mead Johnson. (La Lettre)

Evotec (EVT GY) - Final FY 2025 (EUR): Revenue 788.4mln (prev. 810.4mln Y/Y), EBITDA 41.1mln (prev. 52.3mln Y/Y). Outlook: Revenue 700-780mln (exp. 785.1mln). (Evotec)

Energy/Airlines/Miners related to geopols - Broad risk on sentiment after the US and Iran agree to a conditional two-week ceasefire; Euro Stoxx 50 indicated higher by 4.3%. US President Trump announced he is to suspend the bombing of Iran for two weeks, subject to Iran opening up the Strait of Hormuz, while he stated that this will be a double-sided ceasefire.